Consumption of flaxseed was associated with an 18% lower risk of breast cancer, and consumption of flax bread was associated with a 23% lower risk of breast cancer according to a study from Cancer Care Ontario.

Women who had mumps had a 19% lower risk of ovarian cancer according to a study from researchers from Harvard Medical School.

This is more evidence that childhood illnesses may help to protect us from heart attack, stroke and certain cancers.

People who had childhood measles, versus those who did not, were

• 66% less likely to have Hodgkin’s lymphoma
• 40% less likely to have non-Hodgkin’s lymphoma
• 71% less likely to have follicular B-cell non-Hodgkin’s lymphoma.

People who had childhood chickenpox, versus those who did not, were 47% less likely to have Hodgkin’s lymphoma according to a study from Italy.

This is more evidence that childhood illnesses may help to protect us from certain diseases including heart attack, stroke and certain cancers.

People who reported a history of three (3) childhood infections or more were 40% less likely to have non-Hodgkin’s lymphoma compared with those that reported no infection according to a 2005 study.

People who reported a history of childhood measles were 66% less likely to have Hodgkin’s lymphoma compared with those that reported not having had childhood measles according to a 2005 study.

People who reported a history of childhood measles were 40% less likely to have non-Hodgkin’s lymphoma compared with those that reported not having had childhood measles according to a 2005 study.

People who reported a history of childhood chickenpox 47% less likely to have non-Hodgkin’s lymphoma compared with those that reported not having had childhood measles according to a 2005 study.

Statins do not increase cancer survival as some studies have claimed.

When researchers eliminated biases from study designs, they found that there was no difference in cancer survival between statin users and non-users.

There was no difference in cancer survival between users and non-users (0% difference), but there was a 7% increased risk of dying overall in statin users versus non-users during the 3-year follow-up period, but this difference was not statistically significant.

Prolonged use of statins for more than 4 years was associated with an 18% increased risk of lung cancer according to a recent analysis of data from 574 UK general practices from 1998-2008.

Prolonged use of statins for more than 4 years was associated with a 23% increased risk of colorectal cancer according to a recent analysis of data from 574 UK general practices from 1998-2008.

Prolonged use of atorvastatin (Lipitor) for more than 4 years was associated with a 51% increased risk of colorectal cancer.

Prolonged use of statins for more than 4 years was associated with a 29% increased risk of bladder cancer according to a recent analysis of data from 574 UK general practices from 1998-2008.

People given the statin, pravastatin (Pravachol), had 25% more cancer than those given a placebo in the PROSPER trial.

• 65% more breast cancer
• 46% more gastrointestinal cancer
• 12% more respiratory cancer
• 41% more other cancers
• and they did not including non-melanoma skin cancer.
  (Previous studies have found that statins increase the risk of non-melanoma skin cancers.)

Women given the statin, pravastatin (Pravachol), had 12-times as much breast cancer as women given a placebo in the CARE trial.

Drug companies and their paid researchers have tried to convince people that statins lower the risk of cancer, but this study and many others suggest that the exact opposite is true — that statins increase the risk of cancer, not decrease the risk.

Long-term statin use (10 years or more) is associated with a more than 2-fold increased risk of breast cancer according to researchers at the Fred Hutchinson Cancer Research Center in Seattle, Washington.

Drug companies 
and their paid researchers have tried to convince people that 
statins lower the risk of cancer,
 but this study 
and many others 
suggest that the 
exact opposite is true — 
that statins increase the risk of cancer, not decrease the risk.

High levels of leisure-time physical activity were associated with a lower risk of 13 types of cancer when compared to people with low levels of leisure-time physical activity according to a study done by researchers at the U.S. National Cancer Institute.

The 13 cancers associated with a lower risk were:

• 10% lower risk of breast cancer
• 13% lower risk of bladder cancer
• 13% lower risk of rectal cancer
• 15% lower risk of head and neck cancer
• 16% lower risk of colon cancer
• 17% lower risk of multiple myeloma
• 20% lower risk of myeloid leukemia
• 21% lower risk of endometrial cancer
• 22% lower risk of gastric cardia
• 23% lower risk of kidney cancer
• 26% lower risk of lung cancer
• 27% lower risk of liver cancer
• 42% lower risk of esophageal cancer

Do statins increase cancer?

Yes, according to a letter published in Current Oncology.

The letter starts out by saying “prospective data suggest that statins actually increase cancer in certain segments of the population.”

Here are other quotes from the letter.

A 10% increase in the consumption of ultra-processed foods was associated with a 12% higher overall cancer risk according to a large study from France.

“In this large prospective study, a 10% increase in the proportion of ultra-processed foods in the diet was associated with a significant increase of greater than 10% in risks of overall and breast cancer,” the authors of the study concluded.

A 10% increase in the consumption of ultra-processed foods was associated with a 11% higher breast cancer risk according to a large study from France.

“In this large prospective study, a 10% increase in the proportion of ultra-processed foods in the diet was associated with a significant increase of greater than 10% in risks of overall and breast cancer,” the authors of the study concluded.

Among non-smokers, a 2 cup/day increase in coffee consumption was associated with a:

• 3% lower risk of dying from breast cancer
• 3% lower risk of dying from colorectal cancer
• 8% lower risk of dying from liver cancer

during a 30-year follow-up (1982-2012).

Among smokers and former-smokers, coffee consumption was associated with an increase in cancer deaths.

The study, done by the American Cancer Society, included 922,896 Cancer Prevention Study-II participants aged 28-94 years who completed a four-page questionnaire and were cancer free at baseline in 1982.

“These findings are consistent with many other studies that suggest coffee drinking is associated with a lower risk of colorectal, liver, female breast and head and neck cancer,” the authors of the study concluded.

Among non-smokers, consuming 2-3 cups of coffee per day was associated with a:

• 28% lower risk of dying from head & neck cancer

during a 30-year follow-up (1982-2012).

Among smokers and former-smokers, coffee consumption was associated with an increase in cancer deaths.

The study, done by the American Cancer Society, included 922,896 Cancer Prevention Study-II participants aged 28-94 years who completed a four-page questionnaire and were cancer free at baseline in 1982.

“These findings are consistent with many other studies that suggest coffee drinking is associated with a lower risk of colorectal, liver, female breast and head and neck cancer,” the authors of the study concluded.

Among non-smokers, a 2 cup/day increase in coffee consumption was associated with a:

• 7% increased risk of dying from esophageal cancer

during a 30-year follow-up (1982-2012).

However, the risk of dying from breast cancer, colorectal cancer and liver cancer was reduced in non-smokers.

Among smokers and former-smokers, coffee consumption was associated with an increase in cancer deaths.

The study, done by the American Cancer Society, included 922,896 Cancer Prevention Study-II participants aged 28-94 years who completed a four-page questionnaire and were cancer free at baseline in 1982.

“These findings are consistent with many other studies that suggest coffee drinking is associated with a lower risk of colorectal, liver, female breast and head and neck cancer,” the authors of the study concluded.

There were 25% more new cancers in elderly people 70-82 who were given 40 mg of pravastatin (Pravachol) per day to lower cholesterol compared to those given a placebo according to the PROSPER trial.

Men with low HDL cholesterol levels of 30 mg/dl or less were 61% times more likely to die from cancer during an average follow-up of 4.9 years than men with HDL levels of 41-50 mg/dl according to a 2016 study from Canada.

The study found that HDL levels that were either too high (>90 mg/dl) or too low (≤30 mg/dl) were associated with an increased risk of death when compared to men and women with more moderate HDL levels (41-80 mg/dl).

Women with low HDL cholesterol levels of 30 mg/dl or less were 2 times more likely to die from cancer during an average follow-up of 4.9 years than women with HDL levels of 51-60 mg/dl according to a 2016 study from Canada.

The study found that HDL levels that were either too high (>90 mg/dl) or too low (≤30 mg/dl) were associated with an increased risk of death when compared to men and women with more moderate HDL levels (41-80 mg/dl).

Men with high HDL cholesterol levels of greater than 90 mg/dl were 36% more likely to die from cancer during an average follow-up of 4.9 years than men with HDL levels of 51-60 mg/dl according to a 2016 study from Canada.

(3.4 per 1,000 men with HDL levels greater than 90 mg/dl died from cardiovascular disease versus 2.5 men with HDL levels of 51-60 mg/dl. 3.4 divided by 2.5 equals 1.36.)

The study found that HDL levels that were either too high (>90 mg/dl) or too low (≤30 mg/dl) were associated with an increased risk of death when compared to men with more moderate HDL levels (41-80 mg/dl).

Women with high HDL cholesterol levels of greater than 90 mg/dl were 100% more likely to die from cancer during an average follow-up of 4.9 years than women with HDL levels of 61-70 mg/dl according to a 2016 study from Canada.

(2.2 per 1,000 women with HDL levels greater than 90 mg/dl died versus 2.0 women with HDL levels of 61-70 mg/dl. 2.2 divided by 2.0 equals 1.10.)

The study found that HDL levels that were either too high (>90 mg/dl) or too low (≤30 mg/dl) were associated with an increased risk of death when compared to women with more moderate HDL levels (41-80 mg/dl).

Women with high HDL cholesterol levels of greater than 90 mg/dl were 50% more likely to die from causes other than dying from cancer or cardiovascular disease during an average follow-up of 4.9 years than women with HDL levels of 61-70 mg/dl according to a 2016 study from Canada.

(3.0 per 1,000 women with HDL levels greater than 90 mg/dl died versus 2.0 women with HDL levels of 61-70 mg/dl. 3.0 divided by 2.0 equals 1.50.)

The study found that HDL levels that were either too high (>90 mg/dl) or too low (≤30 mg/dl) were associated with an increased risk of death when compared to women with more moderate HDL levels (41-80 mg/dl).

The average age of cancer onset in women drinking 10 or more cups of green tea per day was delayed by 7 years when compared to women who drank 3 cups of green tea or less—74-years-old versus 67-years-old—according to a recent study.

The average age of cancer onset in men drinking 10 or more cups of green tea per day was delayed by 3 years when compared to men who drank 3 cups of green tea or less—67-years-old versus 65-years-old—according to a recent study.

Men consuming over 10 cups of green tea per day were 46% less likely to get cancer over some number of years of follow-up compared to men who consumed less than 3 cups of green tea per day according to a study of 8,552 general residents in Saitama Prefecture, Japan.

Women consuming over 10 cups of green tea per day were 43% less likely to get cancer over some number of years of follow-up compared to women who consumed less than 3 cups of green tea per day according to a study of 8,552 general residents in Saitama Prefecture, Japan.

Vegetarians had a 22% lower risk of colorectal cancer during a 7.3 year follow-up compared to non-vegetarians according to a study from researchers at Loma Linda University in Loma Linda, California, USA.

There was a 19% lower risk of colon cancer and a 29% lower risk of rectal cancer in vegetarians versus non-vegetarians.

“Vegetarian diets are associated with an overall lower incidence of colorectal cancers,” the authors of the study concluded.